1 juill. 2020 - Moderna COVID-19 vaccine candidate
Description:
In July 2020, the Moderna COVID-19 vaccine candidate, mRNA-1273, was shown in a Phase I trial to be immunogenic in a small number of volunteers aged 18–55 yearsAjouté au bande de temps:
Date:
1 juill. 2020
Maintenaint
~ Il y a 5 ans et 3 mois